D. Balayssac

发表

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy

C. Lambert, S. Melnikov, O. Bouché, 2021, Frontiers in Pharmacology.

Use of Psychotropic Medications and Illegal Drugs, and Related Consequences Among French Pharmacy Students – SCEP Study: A Nationwide Cross-Sectional Study

D. Balayssac, B. Pereira, Maxime Darfeuille, 2018, Front. Pharmacol..

Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review

N. Kerckhove, D. Pezet, D. Balayssac, 2017, Front. Pharmacol..

A Polyamine-Deficient Diet Prevents Oxaliplatin-Induced Acute Cold and Mechanical Hypersensitivity in Rats

A. Eschalier, J. Moulinoux, L. Daulhac, 2013, PloS one.

Animal models of chemotherapy-evoked painful peripheral neuropathies

A. Eschalier, D. Balayssac, N. Authier, 2009, Neurotherapeutics.

Burnout in French General Practitioners: A Nationwide Prospective Study

C. Lambert, Bruno Pereira, Lenise M. Parreira, 2021, International journal of environmental research and public health.

Cholinergic Neurotransmission in the Posterior Insular Cortex Is Altered in Preclinical Models of Neuropathic Pain: Key Role of Muscarinic M2 Receptors in Donepezil-Induced Antinociception

A. Eschalier, L. Daulhac, D. Balayssac, 2015, The Journal of Neuroscience.

Work-related stress, associated comorbidities and stress causes in French community pharmacies: a nationwide cross-sectional study

C. Lambert, D. Balayssac, B. Pereira, 2017, PeerJ.

Clinical and Organizational Impact of the AIRSEAL® Insufflation System During Laparoscopic Surgery: A Systematic Review

M. Selvy, D. Balayssac, X. Armoiry, 2020, World Journal of Surgery.

Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives

N. Kerckhove, J. Busserolles, D. Balayssac, 2015, Expert opinion on drug safety.

A new clinically-relevant rat model of letrozole-induced chronic nociceptive disorders.

A. Eschalier, C. Guillet, D. Balayssac, 2021, Toxicology and applied pharmacology.

Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin

D. A. Barrière, A. Eschalier, M. Lazdunski, 2018, Neuropharmacology.

Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet—NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial

A. Eschalier, C. Pétorin, D. Pezet, 2015, BMJ Open.

Emerging Trends in Understanding Chemotherapy-Induced Peripheral Neuropathy

J. Busserolles, D. Balayssac, N. Authier, 2013, Current Pain and Headache Reports.

Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence

A. Eschalier, D. Pezet, D. Balayssac, 2011, Expert opinion on drug safety.

Warmed and humidified carbon dioxide for abdominal laparoscopic surgery: meta-analysis of the current literature

J. Bazin, D. Pezet, D. Balayssac, 2016, Surgical Endoscopy.

Efficacy of donepezil for the treatment of oxaliplatin-induced peripheral neuropathy: DONEPEZOX, a protocol of a proof of concept, randomised, triple-blinded and multicentre trial

C. Lepage, N. Kerckhove, D. Pezet, 2022, BMC cancer.

Clinical assessment of new antineuropathic strategies for chemotherapy-induced peripheral neuropathy: pain should not be the principal endpoint.

N. Kerckhove, D. Pezet, D. Balayssac, 2017, Pain.

Does inhibition of P-glycoprotein lead to drug-drug interactions?

D. Balayssac, N. Authier, A. Cayre, 2005, Toxicology letters.

Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study

J. Bay, N. Kerckhove, M. Selvy, 2022, European Archives of Oto-Rhino-Laryngology.

Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice

L. Richard, D. Balayssac, F. Sturtz, 2021, Frontiers in Pharmacology.

Behavioral and pharmacological description of oxaliplatin-induced painful neuropathy in rat

A. Eschalier, D. Balayssac, N. Authier, 2007, PAIN.

Chemotherapy-Induced Peripheral Neuropathy and New Therapeutic Targets: Preclinical Data of Drug Repositioning

N. Kerckhove, M. Selvy, J. Busserolles, 2022, Douleur et Analgésie.

Response to “Use of Domperidone to Increase Breast Milk Supply: Further Consideration of the Benefit-Risk Ratio Is Required”

D. Balayssac, J. Cardot, M. Zénut, 2015, Journal of human lactation : official journal of International Lactation Consultant Association.

Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat.

A. Eschalier, D. Balayssac, N. Authier, 2007, Toxicology.

Therapeutic management of complex anal fistulas by installing a nitinol closure clip: study protocol of a multicentric randomised controlled trial—FISCLOSE

G. Carrier, D. Pezet, D. Balayssac, 2015, BMJ Open.

Patterns of P‐glycoprotein activity in the nervous system during vincristine‐induced neuropathy in rats

A. Eschalier, J. Maublant, F. Penault-Llorca, 2005, Journal of the peripheral nervous system : JPNS.

The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice

D. A. Barrière, A. Eschalier, J. Busserolles, 2021, International journal of molecular sciences.

Involvement of the multidrug resistance transporters in cisplatin-induced neuropathy in rats. Comparison with the chronic constriction injury model and monoarthritic rats.

A. Eschalier, J. Maublant, F. Penault-Llorca, 2006, European journal of pharmacology.

Perception of pharmacy students toward opioid-related disorders and roles of community pharmacists: A French nationwide cross-sectional study

D. Balayssac, B. Pereira, P. Cuq, 2020, Substance abuse.

The safety of medications used to treat peripheral neuropathic pain, part 1 (antidepressants and antiepileptics): review of double-blind, placebo-controlled, randomized clinical trials

N. Kerckhove, M. Selvy, J. Busserolles, 2020, Expert opinion on drug safety.

Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists’ professional practices

N. Kerckhove, M. Selvy, J. Busserolles, 2021, Supportive Care in Cancer.

Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity

A. Eschalier, J. Busserolles, D. Balayssac, 2021, Molecular Neurobiology.

Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study

J. Bay, N. Kerckhove, M. Selvy, 2021, Frontiers in Pharmacology.

Use of Permacol in Parietal and General Surgery

D. Pezet, D. Balayssac, Bruno Pereira, 2013, Surgical innovation.

Vincristine-Induced Neuropathy in the Rat Is Not Modified by Drug-Drug Interactions with the P-Glycoprotein Inhibitor Verapamil

A. Eschalier, J. Maublant, F. Penault-Llorca, 2008, Chemotherapy.

Burnout, associated comorbidities and coping strategies in French community pharmacies—BOP study: A nationwide cross-sectional study

D. Balayssac, B. Pereira, B. Vennat, 2017, PloS one.

Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup

A. Eschalier, N. Kerckhove, J. Busserolles, 2019, BMJ Open.

Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury—PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial

C. Mourgues, D. Balayssac, V. Sapin, 2019, BMJ Open.

Nociceptive, Visceral, and Cancer Pain

D. Ardid, D. Balayssac, C. Mallet, 2014 .

Use of Domperidone as a Galactagogue Drug

D. Balayssac, J. Cardot, M. Zénut, 2015, Journal of human lactation : official journal of International Lactation Consultant Association.

Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study

O. Bouché, N. Kerckhove, M. Selvy, 2020, Journal of clinical medicine.

The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials

N. Kerckhove, M. Selvy, J. Busserolles, 2020, Expert opinion on drug safety.

Benzodiazepine dependence: focus on withdrawal syndrome.

P. Courty, A. Eschalier, P. Llorca, 2009, Annales pharmaceutiques francaises.

Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study

C. Pétorin, D. Pezet, D. Balayssac, 2016, PloS one.

Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy

A. Eschalier, J. Maublant, D. Balayssac, 2009, Neuroscience Letters.

Assessment of nociception in acrylamide-induced neuropathy in rats

A. Eschalier, D. Balayssac, N. Authier, 2005, Pain.

Cannabis users: Screen systematically, treat individually. A descriptive study of participants in a randomized trial in primary care

C. Lambert, D. Balayssac, N. Authier, 2019, PloS one.

Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study

S. Trévis, D. Balayssac, B. Pereira, 2023, Cancers.

Spinal Substance P and CGRP staining in vincristine, cisplatin, streptozocin or constriction injury-induced neuropathies

D. Balayssac, B. Ling, M. Coudoré-Civiale, 2010 .

Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors.

C. Dumontet, M. Selvy, J. Busserolles, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study

J. Bay, C. Pétorin, D. Balayssac, 2023, European Journal of Cancer Care.

Benzodiazepine dependence: Focus on withdrawal syndrome Dépendance aux benzodiazépines : le syndrome de sevrage

P. Courty, A. Eschalier, D. Balayssac, 2009 .

Assessment of thermal sensitivity in rats using the thermal place preference test: description and application in the study of oxaliplatin-induced acute thermal hypersensitivity and inflammatory pain models

A. Eschalier, D. Balayssac, N. Authier, 2014, Behavioural pharmacology.

Assessment of the advantage of the serum S100B protein biomonitoring in the management of paediatric mild traumatic brain injury—PROS100B: protocol of a multicentre unblinded stepped wedge cluster randomised trial

C. Mourgues, D. Balayssac, V. Sapin, 2019, BMJ Open.

[Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology].

N. Kerckhove, D. Pezet, D. Balayssac, 2018, Bulletin du cancer.

Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine

J. Busserolles, D. Balayssac, C. Demiot, 2023, Toxics.

Epigenetics mechanisms and chronic pain

J. Busserolles, D. Balayssac, J. Ferrier, 2013 .

Motor disorders related to oxaliplatin-induced peripheral neuropathy: long-term severity and impact on quality of life.

N. Kerckhove, M. Selvy, Coralie Gonneau, 2024, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

Exploring Cholinergic Compounds for Peripheral Neuropathic Pain Management: A Comprehensive Scoping Review of Rodent Model Studies

D. Balayssac, Edouard Montigné, 2023, Pharmaceuticals.

Absence of painful neuropathy after chronic oral fluoride intake in Sprague–Dawley and Lou/C rats

D. Jourdan, A. Eschalier, D. Balayssac, 2002, Neuroscience Letters.

Study of the relationship between psychoactive substance use and pain in cancer patients and cancer survivors: A French nationwide cross-sectional study.

D. Balayssac, Bruno Pereira, Charles Ragusa, 2024, International journal of cancer.